Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
At All Doses Evaluated, VAX-24 Was Well-Tolerated and Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) -- -- At ...